These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36121635)

  • 1. miR-188-5p and Host MALAT1 Regulate RBE Cell Migration, Invasion, and Apoptosis via Up-regulating PSMD10 in Cholangiocarcinoma.
    Yin Z; Wang J; Li T; Ma L; Kang J; Liu G
    Appl Biochem Biotechnol; 2023 Jan; 195(1):655-671. PubMed ID: 36121635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis.
    Wang S; Ren L; Shen G; Liu M; Luo J
    Mol Cell Probes; 2020 Jun; 51():101540. PubMed ID: 32084582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
    Wang D; Zhang S; Zhao M; Chen F
    Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-coding RNA MALAT1 Alleviates the Elevated Intraocular Pressure (Eiop)-induced Glaucoma Progression via Sponging miR-149-5p.
    Wang L; Gong J; Wang J; Dan J; Wang P
    Curr Eye Res; 2021 Jun; 46(6):903-911. PubMed ID: 33108931
    [No Abstract]   [Full Text] [Related]  

  • 9. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
    Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
    Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
    Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
    Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
    Cheng B; Rong A; Zhou Q; Li W
    J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
    Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
    J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
    Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X
    Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
    Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
    Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
    Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
    FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.